Mainz Biomed B.V. (MYNZ) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Mainz Biomed announced a 1-for-40 reverse stock split to maintain its Nasdaq listing, aiming to boost its stock price and attract investors. The reverse split, effective December 3, 2024, will adjust the trading price of its shares but leave shareholder ownership percentages unchanged. This move comes after failing to meet Nasdaq’s minimum bid price and stockholders’ equity requirements.
For further insights into MYNZ stock, check out TipRanks’ Stock Analysis page.
